Materials · coverage Jan 13, 2024–Sep 12, 2026
Estimated market comparison · not an official filing fact
Available with Pro
Average post-trade price move across enriched rows. It is historical, sample-limited, does not account for exact execution prices or portfolio weights, and is not evidence that the filing activity caused a market move.
Disclosure alert preview
Based on a real public filing
Thomas H. Kean
$1K - $15K
This watch matched after the disclosure became public. It is not a real-time trade signal. Source checked Sep 28, 2026.
Official filingThis page summarizes public STOCK Act disclosures involving LIN. It is useful for seeing which lawmakers reported LIN transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Sep 12, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
Congressional Trader tracks 30 public STOCK Act disclosures for LINacross 12 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent LIN filing shown here was filed on Sep 12, 2026 by Thomas H. Kean as a purchase. Related lawmakers include Jared Moskowitz, Jefferson Shreve, Kevin Hern, Robert P. Bresnahan, Thomas H. Kean.
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansRecent LIN disclosures include Jared Moskowitz, Jefferson Shreve, Kevin Hern, Robert P. Bresnahan, Thomas H. Kean.
The visible sample currently shows 18 purchases and 12 sales or partial sales.
No. This page summarizes public filings for research and monitoring. It is not investment advice.
